Detalles de la búsqueda
1.
Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation.
Ann Hematol;
2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472362
2.
Prognostic factors in patients with bone marrow hemophagocytosis and its association with hematologic malignancies.
Hematol Oncol;
41(1): 167-177, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305496
3.
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients.
Transfus Med Hemother;
50(1): 39-50, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36818774
4.
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism.
J Thromb Thrombolysis;
53(1): 182-190, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34228248
5.
Periprocedural management and clinical outcomes of invasive procedures after venous thromboembolism: from the COMMAND VTE registry.
J Thromb Thrombolysis;
53(2): 540-549, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34524599
6.
Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma.
Support Care Cancer;
29(7): 3991-3999, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33398428
7.
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays.
J Thromb Thrombolysis;
51(3): 779-788, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728908
8.
Risk and impact of invasive fungal infections in patients with multiple myeloma.
Ann Hematol;
99(8): 1813-1822, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32607596
9.
Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolismã- From the COMMAND VTE Registry.
Circ J;
84(11): 2006-2014, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33012736
10.
D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry.
J Thromb Thrombolysis;
49(4): 551-561, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571121
11.
Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolismã- From the COMMAND VTE Registry.
Circ J;
83(7): 1581-1589, 2019 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142685
12.
Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onsetã- From the COMMAND VTE Registry.
Circ J;
83(6): 1377-1384, 2019 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30930347
13.
Cancer-Associated Venous Thromboembolism in the Real Worldã- From the COMMAND VTE Registry.
Circ J;
83(11): 2271-2281, 2019 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31548438
14.
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry.
J Thromb Thrombolysis;
48(4): 587-595, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278648
15.
Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry.
J Thromb Thrombolysis;
47(3): 444-453, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30673941
16.
Risk factors for post-thrombotic syndrome in patients with deep vein thrombosis: from the COMMAND VTE registry.
Heart Vessels;
34(4): 669-677, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293163
17.
Anticoagulation Therapy for Venous Thromboembolism in the Real Worldã- From the COMMAND VTE Registry.
Circ J;
82(5): 1262-1270, 2018 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29576597
18.
Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.
Hematol Oncol;
35(4): 835-844, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27465587
19.
No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation.
Blood Cells Mol Dis;
55(1): 36-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25976465
20.
Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.
Hematol Oncol;
33(4): 136-44, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25111959